Aminalon 250 mg (Gamma-Aminobutyric Acid) 50 tablets

Aminalon 250 mg Tablets (Gamma-Aminobutyric Acid)

Manufacturer: Borisov Plant of Medical Preparations (Belarus)
Dosage form: Film-coated tablets
Active ingredient: Gamma-aminobutyric acid (GABA) — 250 mg per tablet
ATC Code: N06BX03

Product Description

Aminalon is a nootropic medication containing gamma-aminobutyric acid (GABA) — a natural inhibitory neurotransmitter in the central nervous system. It is designed to improve brain metabolism, enhance memory and concentration, and support recovery of cognitive functions after various brain injuries or circulatory disorders.

The preparation helps to normalize brain activity, improve glucose utilization, and facilitate the elimination of toxic metabolic by-products from brain tissue. Aminalon contributes to the restoration of intellectual and motor functions, and it may also produce a mild psychostimulant and antihypoxic effect.

Pharmacological Action

• Nootropic effect: Enhances mental performance, learning ability, and memory.
• Metabolic support: Improves oxygen and glucose metabolism in brain tissue.
• Neuroprotective effect: Promotes recovery after cerebrovascular accidents, head trauma, or ischemic conditions.
• Regulatory influence: Helps stabilize blood pressure and improve sleep patterns in patients with vascular encephalopathy or hypertension.

Indications

Aminalon is used for:

• Consequences of cerebrovascular disorders (stroke, ischemia).
• Traumatic brain injuries and their residual effects.
• Cerebral atherosclerosis and chronic cerebrovascular insufficiency.
• Intellectual and memory decline in elderly patients.
• Alcoholic encephalopathy and peripheral neuropathies.
• Cerebral palsy and developmental delays in children.
• Motion sickness (seasickness, airsickness) — prevention and treatment.

Dosage and Administration

Route of administration: Oral, preferably before meals.

Adults:
3–3.75 g per day (12–15 tablets of 250 mg), divided into 3 doses.

Children:

• 1–3 years — 1–2 g per day
• 4–6 years — 2–3 g per day
• 7 years and older — up to 3 g per day

For motion sickness:
Adults — 500 mg (2 tablets) three times daily for 3–4 days.
Children over 5 years — 250 mg (1 tablet) three times daily.

Treatment duration:
Usually from 2–3 weeks up to 2–4 months, depending on clinical condition and doctor’s recommendation.

Contraindications

• Hypersensitivity to gamma-aminobutyric acid or other tablet components.
• Acute renal impairment.
• Pregnancy and breastfeeding: Use only if clearly needed and prescribed by a physician.
• Use with caution when operating vehicles or machinery at the beginning of treatment (possible reduced attention).

Possible Side Effects

Most patients tolerate Aminalon well.
However, the following may occur:

• Digestive system: nausea, vomiting, dyspepsia.
• Nervous system: sleep disturbances, irritability, sensation of warmth or heat.
• Cardiovascular system: blood pressure fluctuations.
• Allergic reactions: rash, itching, skin redness.

If any adverse reactions occur, discontinue use and consult a physician.

Composition

Active substance:

• Gamma-aminobutyric acid — 250 mg

Excipients:
Microcrystalline cellulose, povidone, colloidal silicon dioxide, magnesium stearate, and film coating components (e.g. Opadry II white 85F18422).

Storage Conditions

• Store in the original package at a temperature not exceeding 25 °C.
• Keep away from moisture and direct sunlight.
• Keep out of the reach of children.

Shelf life: 2 years.
Prescription status: Prescription-only medicine (varies by country).

Packaging

• 10 tablets per blister.
• 5 or 10 blisters per carton (50 or 100 tablets total).

Important Note

Aminalon is a prescription nootropic medication and should only be taken under medical supervision.
Self-medication is not recommended. Always follow the dosing schedule prescribed by your doctor.

Contact us in Telegram